Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the Curve

20260 citationsJournal Articlehybrid Open Access

Authors

Clinical trials registration number: ClinicalTrials.gov NCT05166421.

Good health and well-being

Published in: Clinical Pharmacokinetics

Field-Weighted Citation Impact: 0.00